Bank of Montreal Can lifted its position in shares of Equifax Inc. (NYSE:EFX) by 31.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 112,465 shares of the financial services provider’s stock after purchasing an additional 23,037 shares during the quarter. Bank of Montreal Can owned 0.28% of Equifax worth $22,586,000 as of its most recent SEC filing.
Other institutional investors have also bought and sold shares of the company. Stelac Advisory Services LLC purchased a new stake in shares of Equifax in the 4th quarter valued at $131,000. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Equifax in the 4th quarter valued at $147,000. Baker Ellis Asset Management LLC increased its position in shares of Equifax by 441.2% in the 4th quarter. Baker Ellis Asset Management LLC now owns 279 shares of the financial services provider’s stock valued at $187,000 after purchasing an additional 232 shares during the last quarter. Cerebellum GP LLC purchased a new stake in shares of Equifax in the 4th quarter valued at $201,000. Finally, Acropolis Investment Management LLC purchased a new stake in shares of Equifax in the 4th quarter valued at $202,000. Institutional investors and hedge funds own 86.98% of the company’s stock.
Get Equifax alerts:
Several equities analysts have weighed in on the company. Credit Suisse Group reiterated a “buy” rating and issued a $105.00 price objective on shares of Equifax in a research note on Friday, February 1st. Wells Fargo & Co set a $116.00 price objective on Equifax and gave the company a “buy” rating in a research note on Wednesday, January 2nd. Zacks Investment Research upgraded Equifax from a “hold” rating to a “buy” rating and set a $118.00 price objective on the stock in a research note on Tuesday, January 29th. Deutsche Bank set a $124.00 price objective on Equifax and gave the company a “buy” rating in a research note on Wednesday, January 2nd. Finally, KeyCorp reiterated a “buy” rating and issued a $115.00 price objective on shares of Equifax in a research note on Friday, February 2nd. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $117.50.
NYSE:EFX opened at $101.00 on Friday. The company has a market capitalization of $19.58 billion, a PE ratio of 17.49, a PEG ratio of 1.10 and a beta of 1.18. Equifax Inc. has a 52 week low of $89.32 and a 52 week high of $110.53. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.30 and a current ratio of 1.30.
Equifax (NYSE:EFX) last released its quarterly earnings results on Tuesday, January 29th. The financial services provider reported $1.44 EPS for the quarter, beating the Zacks’ consensus estimate of $1.37 by $0.07. The firm had revenue of $779.00 million for the quarter, compared to analysts’ expectations of $779.39 million. Equifax had a return on equity of 108.98% and a net margin of 19.59%. Equifax’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.21 EPS. As a group, sell-side analysts expect that Equifax Inc. will post 6.11 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The original version of this story can be accessed at .
Equifax Inc provides information solutions and scores across various transaction-related functions. It operates